Procaps Group SA Cash Flow Conversion Efficiency

Latest as of September 2023: 1.232x

Procaps Group SA cash flow conversion efficiency. Based on the latest financial reports, Procaps Group SA (PROC) has a cash flow conversion efficiency ratio of 1.232x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($47.39 Million) by net assets ($38.45 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Procaps Group SA (2019–2022)

Cash flow conversion efficiency of Procaps Group SA from 2019 to 2022. This chart illustrates how Procaps Group SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Procaps Group SA share price for real-time trading data and today's change.

Procaps Group SA Cash Flow Conversion Ratio Explained

Procaps Group SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Procaps Group SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Procaps Group SA ranked by their cash flow conversion efficiency. Also see Procaps Group SA (PROC) market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Rafael Microelectronics
TWO:6568
0.045x
LB Semicon Inc
KQ:061970
0.045x
SaraminHR Co.Ltd
KQ:143240
-0.026x
Oriental Precision & Engineering Co.Ltd
KQ:014940
0.088x
Lokum Deweloper SA
WAR:LKD
-0.049x
Corner Growth Acquisition Corp
NASDAQ:COOL
0.000x
Aftermath Silver Ltd
V:AAG
-0.084x
American Resources Corp Class A
NASDAQ:AREC
-0.127x

Annual Cash Flow Conversion Efficiency for Procaps Group SA (2019–2022)

The table below shows the annual cash flow conversion efficiency of Procaps Group SA from 2019 to 2022. Review Procaps Group SA (PROC) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2022-12-31 $-1.88 Million $14.11 Million -7.511x -672.00%
2021-12-31 $-38.34 Million $37.30 Million -0.973x -249.39%
2020-12-31 $-254.68 Million $70.92 Million -0.278x +0.52%
2019-12-31 $-243.95 Million $68.29 Million -0.280x --

About Procaps Group SA

NASDAQ:PROC USA Drug Manufacturers - Specialty & Generic
Market Cap
$124.11 Million
Market Cap Rank
#18474 Global
#4317 in USA
Share Price
$1.10
Change (1 day)
+0.00%
52-Week Range
$1.10 - $1.10
All Time High
$10.76
About

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use… Read more